Skip Navigation


Human Molecular Genetics Advance Access originally published online on February 19, 2004
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Supplementary Material
Right arrow All Versions of this Article:
13/8/783    most recent
ddh099v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (30)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Tang, K.
Right arrow Articles by Lee, C. G.L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tang, K.
Right arrow Articles by Lee, C. G.L.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Human Molecular Genetics, 2004, Vol. 13, No. 8 783-797
DOI: 10.1093/hmg/ddh099
Human Molecular Genetics, Vol. 13, No. 8 © Oxford University Press 2004; all rights reserved

Genomic evidence for recent positive selection at the human MDR1 gene locus

Kun Tang1, Li Peng Wong1, Edmund J.D. Lee2, Samuel S. Chong3,5 and Caroline G.L. Lee1,4,*

1Department of Biochemistry, 2Department of Pharmacology and 3Department of Pediatrics and Obstetrics/Gynecology, National University of Singapore, Singapore, 4Division of Medical Sciences, National Cancer Center, Singapore and 5Department of Pediatrics and Gynecology/Obstetrics, The Johns Hopkins University School of Medicine, Baltimore, MD, USA

Received August 21, 2003; Accepted February 10, 2004

The MDR1 multidrug transporter regulates the traffic of drugs, peptides and xenobiotics into the body as well as sensitive tissues like the brain, germ cells and the developing fetus. Hence, it may influence an individual's response to drugs as well as his/her susceptibility to complex diseases in which environmental factors, especially xenobiotics, play a role. Polymorphisms within this gene, especially single-nucleotide polymorphism e26/3435(C/T), have been variously associated with differences in MDR1 expression, function, drug response and disease susceptibility. Here, we report the detailed characterization of the haplotype and linkage disequilibrium architecture of the entire 200 kb of the MDR1 gene in five world populations, namely, Chinese, Malays, Indians, Caucasians and African-Americans. We observed varied haplotype diversity across the entire gene in the different populations. The major haplotype mh5, which contains the subhaplotype e12/1236T–e21/2677T–e26/3435T, is highly represented among the four non-African populations, while mh7, which contains the subhaplotype e12/1236C–e21/2677G–e26/3435C, accounts for over a third of African-American chromosomes. These observations are inconsistent with a simple population evolution model, but instead are suggestive of recent historical events that have maintained such long range linkage disequilibrium. Using a modified long-range haplotype test, we found statistically significant evidence of recent positive selection for the e21/2677T and e26/3435T alleles in the Chinese population, and for the e26/3435T allele in the Malay population. Interestingly, we also detected evidence for positive selection of the alternative allele e26/3435C in the African-American population. These data suggest that independent mutational events may have occurred on the mh5 and mh7 haplotypes of the MDR1 gene to confer positive selection in the non-African and African-American populations, respectively.

* To whom correspondence should be addressed at: Division of Medical Sciences, National Cancer Center, Level 6, Lab 5, 11 Hospital Drive, Singapore 169610. Tel: +65 64368353; Fax: +65 62241778; Email: bchleec{at}nus.edu.sg


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Hum Mol GenetHome page
O. Levran, K. O'Hara, E. Peles, D. Li, S. Barral, B. Ray, L. Borg, J. Ott, M. Adelson, and M. J. Kreek
ABCB1 (MDR1) genetic variants are associated with methadone doses required for effective treatment of heroin dependence
Hum. Mol. Genet., July 15, 2008; 17(14): 2219 - 2227.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
K. Y. Urayama, J. K. Wiencke, P. A. Buffler, A. P. Chokkalingam, C. Metayer, and J. L. Wiemels
MDR1 Gene Variants, Indoor Insecticide Exposure, and the Risk of Childhood Acute Lymphoblastic Leukemia
Cancer Epidemiol. Biomarkers Prev., June 1, 2007; 16(6): 1172 - 1177.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
Z. Wang, J. Wang, E. Tantoso, B. Wang, A. Y.P. Tai, L. L.P.J. Ooi, S. S. Chong, and C. G.L. Lee
Signatures of recent positive selection at the ATP-binding cassette drug transporter superfamily gene loci
Hum. Mol. Genet., June 1, 2007; 16(11): 1367 - 1380.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
L. D. Lewis, A. A. Miller, G. L. Rosner, J. E. Dowell, M. Valdivieso, M. V. Relling, M. J. Egorin, R. R. Bies, D. R. Hollis, E. G. Levine, et al.
A Comparison of the Pharmacokinetics and Pharmacodynamics of Docetaxel between African-American and Caucasian Cancer Patients: CALGB 9871
Clin. Cancer Res., June 1, 2007; 13(11): 3302 - 3311.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
B. Wang, S. Ngoi, J. Wang, S. S. Chong, and C. G. L. Lee
The Promoter Region of the MDR1 Gene Is Largely Invariant, but Different Single Nucleotide Polymorphism Haplotypes Affect MDR1 Promoter Activity Differently in Different Cell Lines
Mol. Pharmacol., July 1, 2006; 70(1): 267 - 276.
[Abstract] [Full Text] [PDF]


Home page
J Clin PharmacolHome page
P. Song, J. K. Lamba, L. Zhang, E. Schuetz, N. Shukla, B. Meibohm, and C. R. Yates
G2677T and C3435T Genotype and Haplotype Are Associated With Hepatic ABCB1 (MDR1) Expression.
J. Clin. Pharmacol., March 1, 2006; 46(3): 373 - 379.
[Full Text] [PDF]


Home page
Hum Mol GenetHome page
Z. Wang, B. Wang, K. Tang, E. J.D. Lee, S. S. Chong, and C. G.L. Lee
A functional polymorphism within the MRP1 gene locus identified through its genomic signature of positive selection
Hum. Mol. Genet., July 15, 2005; 14(14): 2075 - 2087.
[Abstract] [Full Text] [PDF]


Home page
The Annals of PharmacotherapyHome page
P. M Beringer and R. L Slaughter
Transporters and Their Impact on Drug Disposition
Ann. Pharmacother., June 1, 2005; 39(6): 1097 - 1108.
[Abstract] [Full Text] [PDF]


Home page
Arch NeurolHome page
E.-K. Tan, D. K.-Y. Chan, P.-W. Ng, J. Woo, Y. Y. Teo, K. Tang, L.-P. Wong, S. S. Chong, C. Tan, H. Shen, et al.
Effect of MDR1 Haplotype on Risk of Parkinson Disease
Arch Neurol, March 1, 2005; 62(3): 460 - 464.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.